News > Zydus Cadila gets USFDA nod for diabetes medication
Zydus Cadila gets USFDA nod for diabetes medication
The Hindu | 06/09/2021 01:49 PM | Click to read full article
Drug firm Zydus Cadila on September 6 said it has received approval from the U.S. health regulator to market Sitagliptin, a medicine indicated to treat diabetes.
The company said its subsidiary has received tentative approval from the United States Food and Drug Administration (FDA) for its new drug application for Sitagliptin base 25, 50 and 100 mg tablets.
